BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3032548)

  • 1. Glucose turnover in insulinoma--a case report.
    Hanna AK; Vranic M; Zinman B
    Diabetes Res Clin Pract; 1987; 3(2):111-4. PubMed ID: 3032548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise in dogs.
    Wasserman DH; Lickley HL; Vranic M
    J Clin Invest; 1984 Oct; 74(4):1404-13. PubMed ID: 6148356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of hypoglycemia in insulinoma patients: suppression of hepatic glucose production by insulin.
    Rizza RA; Haymond MW; Verdonk CA; Mandarino LJ; Miles JM; Service FJ; Gerich JE
    Diabetes; 1981 May; 30(5):377-81. PubMed ID: 6262168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of suppression of insulin secretion by exercise in patients with insulinoma.
    Järhult J; Ericsson M; Holst J; Ingemansson S
    Clin Endocrinol (Oxf); 1981 Oct; 15(4):391-4. PubMed ID: 6274547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of transplantation and resection of a radiation-induced rat insulinoma on glucose homeostasis and the endocrine pancreas.
    Flatt PR; Tan KS; Bailey CJ; Powell CJ; Swanston-Flatt SK; Marks V
    Br J Cancer; 1986 Oct; 54(4):685-92. PubMed ID: 2877684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin synthesis inhibitors impair hepatic glucose production in response to glucagon and epinephrine stimulation.
    Miller JD; Ganguli S; Sperling MA
    Diabetes; 1983 May; 32(5):439-44. PubMed ID: 6301913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in glucagon do not play an essential role in the glucoregulatory responses to mild hyperinsulinemia in dogs.
    Werther GA; Banach W; Joffe S; Artal R; Sperling MA
    Diabetes Res Clin Pract; 1987; 3(1):55-61. PubMed ID: 2880702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucoregulation in alloxan-diabetic dogs.
    Lussier B; Vranic M; Kovacevic N; Hetenyi G
    Metabolism; 1986 Jan; 35(1):18-24. PubMed ID: 3510360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta cell response to the hyperglycaemic clamp in three patients with insulinoma: a study using a hyperglycaemic glucose clamp.
    García López JM; De la Fuente A; Tomé MA; Cabezas-Cerrato J
    Horm Metab Res; 1987 Apr; 19(4):160-3. PubMed ID: 3034753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients.
    Del Prato S; Riccio A; Vigili de Kreutzenberg S; Dorella M; Avogaro A; Marescotti MC; Tiengo A
    Metabolism; 1993 Jan; 42(1):24-9. PubMed ID: 8446044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and C-peptide in plasma and tumor of insulinoma patients.
    Ohneda A; Sakai T; Kobayashi T; Nihei J
    Tohoku J Exp Med; 1983 Jan; 139(1):73-81. PubMed ID: 6301101
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of ketone bodies on glucose production and utilization in the miniature pig.
    Müller MJ; Paschen U; Seitz HJ
    J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs.
    Vranic M; Kawamori R; Pek S; Kovacevic N; Wrenshall GA
    J Clin Invest; 1976 Feb; 57(2):245-55. PubMed ID: 1254723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperinsulinaemia and insulin insensitivity: studies in subjects with insulinoma.
    Nankervis A; Proietto J; Aitken P; Alford F
    Diabetologia; 1985 Jul; 28(7):427-31. PubMed ID: 2995184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma insulin response to various secretagogues in insulinoma.
    Ohneda A; Kobayashi T; Nihei J
    Tohoku J Exp Med; 1982 Apr; 136(4):447-57. PubMed ID: 6285549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G; Lickley L; Vranic M
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential insulin responses to oral and intravenous glucose in the transplantable rat insulinoma--a role for GIP.
    Tan KS; Kwasowski P; Marks V
    Regul Pept; 1986 Jan; 13(2):163-8. PubMed ID: 3006156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-peptide suppression test for insulinoma.
    Service FJ; Horwitz DL; Rubenstein AH; Kuzuya H; Mako ME; Reynolds C; Molnar GD
    J Lab Clin Med; 1977 Jul; 90(1):180-6. PubMed ID: 194989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon and glucose dynamics in sheep: evidence for glucagon resistance in the fetus.
    Devaskar SU; Ganguli S; Styer D; Devaskar UP; Sperling MA
    Am J Physiol; 1984 Mar; 246(3 Pt 1):E256-65. PubMed ID: 6703054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the mechanism underlying the influence of alanine infusion on glucose dynamics in the dog.
    Saccà L; Trimarco B; Perez G; Rengo F
    Diabetes; 1977 Apr; 26(4):262-70. PubMed ID: 300341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.